0 results for 'Lieff Cabraser'
Misrepresentations Did Not Impact Stock Price; Shareholder Class Decertified
New York Legal Award Honorees Selected for 2023
The full list of our honorees, including Lifetime Achievement Award Winners, Distinguished Leaders, Diversity Initiative Winners, In-House Impact Winners, Innovation Award Winners, Litigation Departments of the Year, Dealmakers of the Year, Rising Stars and the finalists for Attorney of the Year.Celebrating Outstanding Achievements: The 2023 Elite Trial Lawyers
The National Law Journal is proud to recognize professional excellence in plaintiffs litigation as well as lifetime achievements and diversity and inclusion initiatives. For the first time, the Elite Trial Lawyers awards also included The Plaintiffs Firm of the Year.Tech Firms Slow to Ditch 'Stack Ranking,' Despite Evidence It Saps Worker Morale, Productivity
The employee-review system, which results in 10% of workers being classified as low performers, has appeal in the analytically inclined tech industry. But critics say it invites arbitrary judgments and bias.Meet the Diverse 'New Faces and Voices' in MDL, Including 1 Birmingham Lawyer
In multidistrict litigation dockets created in 2022, about 13% of plaintiffs lawyers appointed to leadership posts were not white, according to Law.com's exclusive data. That's down from the 16% in 2021, and 14% in 2020, but up from 2016 to 2019, when white attorneys dominated with 95% of appointments.View more book results for the query "Lieff Cabraser"
The 2023 NLJ 500: Headcount Growth Accelerated For Firms
Law firms bulk up associate and nonequity ranks across practice areas in this year's NLJ 500.Meet the Diverse 'New Faces and Voices' in Multidistrict Litigation
In multidistrict litigation dockets created in 2022, about 13% of plaintiffs lawyers appointed to leadership posts were not white, according to Law.com's exclusive data. That's down from the 16% in 2021, and 14% in 2020, but up from 2016 to 2019, when white attorneys dominated with 95% of appointments.CVS, Walgreens Opioid Settlement Money Expected by Year's End
Consistent with previous "Big Three" opioid distributor agreements, the settlements require 85% of the funds be allocated to programs that address the ongoing opioid crisis through treatment, education and prevention efforts.Settlement Money From CVS, Walgreens Opioid Settlement Coming by Year's End
Consistent with previous "Big Three" opioid distributor agreements, the settlements require 85% of the funds be allocated to programs that address the ongoing opioid crisis through treatment, education and prevention efforts.Settlement Money From CVS, Walgreens Opioid Settlement Coming by Year's End
If approved by the court, California might receive up to approximately $375 million from the Teva settlement and up to approximately $205 million from the Allergan settlement, said California Attorney General Rob Bonta.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Employee Happiness Playbook: The 3 R's for Business Success in 2024
Brought to you by Amazing Workplace, Inc.
Download Now
The Positive Impact of AI at Small Law Firms: 4 Key Insights
Brought to you by LexisNexis®
Download Now
Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus
Brought to you by HaystackID
Download Now
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now